Biodexa Pharmaceuticals Plc is an early-stage biopharmaceutical company focused on developing and licensing product candidates in clinical and preclinical development phases. The company aims to generate revenue through licensing partnerships, earning royalty and milestone income. It has incurred significant losses since inception, with an accumulated deficit of £155.67 million as of December 31, 2025, and no sources of recurring revenue.
Look up BDRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on BDRX, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/BDRX (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.